Ginkgo Bioworks Holdings Inc. Class A (DNA) Fundamentals

Ginkgo Bioworks Holdings Inc is building a platform to enable customers to program cells as easily to program computers. The company's platform is market agnostic and enables biotechnology applications across diverse markets, from food and agriculture to industrial chemicals to pharmaceuticals.
SHARE INFORMATION
Market Cap$ 4,423,825,983
Shares Outstanding1,776,636,941
Float651,350,586
Percent Float36.66%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 313,837,000
Latest Fiscal EPS$ -1.39
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions364
Institutional Holdings Date2022-05-31
Institutional Bought Previous 3 Months177,356,290
Institutional Holdings Percent61.1%
Institutional Sold Previous 3 Months356,974,758
Insider Holdings Date2022-05-31
Insider Bought Previous 3 Months7,112,064
Insider Holdings Percent0.3
Insider Sold Previous 3 Months289,898
Insider Shares Owned4,707,303
TRADING INFO
52 Week High$ 15.86
52 Week Low$ 2.09
52 Week High Change$ 0.00
21 Day Moving Average$ 2.909
21 Day Extended Moving Average$ 2.7784
50 Day Moving Average$ 3.0112
50 Day Extended Moving Average$ 3.1077
200 Day Moving Average$ 7.0645
200 Day Extended Moving Average$ 6.2757
10 Day Average Volume27,867,042
20 Day Average Volume25,223,877
30 Day Average Volume25,890,182
50 Day Average Volume23,131,246
Alpha-0.129147
Beta2.0877
Standard Deviation0.180904
R20.368961
7 Day Price Change$ -0.10
7 Day Percent Change-3.86%
21 Day Price Change$ -0.49
21 Day Percent Change-16.44%
30 Day Price Change$ -0.12
30 Day Percent Change-4.6%
Month to Date Price Change$ -0.59
Month to Date Percent Change-19.16%
Quarter to Date Price Change$ -1.54
Quarter to Date Percent Change-38.21%
180 Day Price Change$ -8.58
180 Day Percent Change-77.51%
200 Day Price Change$ -6.16
200 Day Percent Change-71.21%
Year to Date Price Change$ -5.82
Year to Date Percent Change-70.04%

Ginkgo Bioworks Holdings Inc. Class A (DNA) Key Ratios

PROFITABILITY
EBIT Margin-537.2%
EBITDA Margin-529.7%
Pre-Tax Profit Margin0.0%
Profit Margin Count0.0%
Gross Margin56.3%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 438,145,000
Revenue Per Share$ 0.4007
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book2.80
Total Debt To Equity0.00
Int Coverage-1,025.60
Current Ratio10.70
Leverage Ratio1.30
Quick Ratio10.40
Long Term Debt To Capital0.02
VALUATION MEASURES
PE Ratio-1.40
Enterprise Value$ 2,869,332,135
Price to Sales6.2145
Price to Free Cash-14.30
PE High Last 5 Years0.00
Price To Book2.70
Price To Cash Flow0.00
PE Low Last 5 Years0.00
Price to Tangible Book2.80
MANAGEMENT EFFECTIVENESS
Receivables Turnover4.50
Invoice Turnover44.00
Assets Turnover0.30
Return Assets-116.91
Return on Equity-152.18
Return on Capital-149.45

Ginkgo Bioworks Holdings Inc. Class A (DNA) Profile

PROFILE INFO
Issue TypeCS
SEC Type-
AuditorErnst & Young LLP
CEOJason Kelly
Emplyoees641
Last AuditUQ
CIK0001830214
IndustryBiotechnology
SectorHealthcare
NAICSResearch and Development in Biotechnology (except Nanobiotechnology)(541714)
CONTACT INFO
Address27 Drydock Avenue
8th Floor
Boston, MA 2210
Websitehttps://www.ginkgobioworks.com
Facsimile-
Telephone+1 877 422-5362
Email-
Your Recent History
NYSE
DNA
Ginkgo Bio..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:us D:20220625 22:42:20